Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent - ecancer
Diclofenac sodium 100mg Tablet
Painkiller heart attack risk: Don't stop taking Diclofenac pills but talk to your GP | Daily Mail Online
CD73, a Promising Therapeutic Target of Diclofenac, Promotes Metastasis of Pancreatic Cancer through a Nucleotidase Independent Mechanism - Liu - 2023 - Advanced Science - Wiley Online Library
What is Diclofenac (Voltaren)? | Live Science
Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent - ecancer
Study points to cause of safety concerns in painkiller diclofenac | WSU Insider | Washington State University
NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future | Journal of Medicinal Chemistry
Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases
Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases
Antioxidants | Free Full-Text | Diclofenac: A Nonsteroidal Anti-Inflammatory Drug Inducing Cancer Cell Death by Inhibiting Microtubule Polymerization and Autophagy Flux
Diclofenac Sodium | New Drug Approvals
Frontiers | Targeting cancer-related inflammation with non-steroidal anti-inflammatory drugs: Perspectives in pharmacogenomics
Diclofenac Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer by Modulation of VEGF Levels and Arginase Activity | PLOS ONE
Diclofenac Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer by Modulation of VEGF Levels and Arginase Activity | PLOS ONE
Anticancer effects of non-steroidal anti-inflammatory drugs against cancer cells and cancer stem cells - ScienceDirect
Treatment of actinic keratosis through inhibition of cyclooxygenase‐2: Potential mechanism of action of diclofenac sodium 3% in hyaluronic acid 2.5% - Thomas - 2019 - Dermatologic Therapy - Wiley Online Library
Metabolic therapies inhibit tumor growth in vivo and in silico | Scientific Reports
Diclofenac Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer by Modulation of VEGF Levels and Arginase Activity | PLOS ONE
Diclofenac - Wikipedia
Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent - ecancer
Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases
Diclofenac Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer by Modulation of VEGF Levels and Arginase Activity | PLOS ONE
NSAIDs - MedShadow Foundation | Independent Health & Wellness Journalism
